TRI-CIRA 28
TRI-CIRA 28
Approved
DIN Number
02508095
Drug Class
Human
Market Date
Mar 8, 2021
Company
HC
Apotex Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02508095
AIG Number0636783002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G03AB09 NORGESTIMATE AND ETHINYLESTRADIOL
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:12.00
Health Canada Classification
ACTIVE INGREDIENTS (4)
ETHINYL ESTRADIOLActive
Strength: 0.035 MG
Monograph: ETHINYL ESTRADIOL
NORGESTIMATEActive
Strength: 0.18 MG
Monograph: NORGESTIMATE
NORGESTIMATEActive
Strength: 0.215 MG
Monograph: NORGESTIMATE
NORGESTIMATEActive
Strength: 0.25 MG
Monograph: NORGESTIMATE